• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Advances in Environmental Biology
Advances in Environmental Biology

... Advances in Environmental Biology, 8(1) January 2014, Pages: 108-114 ...
Development of BT1718, a novel Bicycle Drug Conjugate for the
Development of BT1718, a novel Bicycle Drug Conjugate for the

... high affinity and exquisite selectivity. In in vitro cytotoxicity assays, BT1718 kills MT1-MMP expressing EBC-1 cells with an IC50~1nM. Figure 2. Efficacy of BT1718 in NSCLC xenograft models. BT1718 was dosed at 1, 3, 10 mg/kg, twice weekly, iv. (a) EBC-1 xenograft, complete clearance of tumour was ...
Antipsychotic dosing: found in translation
Antipsychotic dosing: found in translation

Pain Assessment and Management in Companion Animals
Pain Assessment and Management in Companion Animals

... When an opioid is administered to an animal, three key processes determine the outcome of the opioid/receptor interaction: a. Selectivity: Opioids can act at mu, kappa, delta, or any combination of the three receptor types. b. Efficacy: Drugs can be pure agonists (inducing a maximal response once ...
Compare and Contrast: IBS/IBD
Compare and Contrast: IBS/IBD

... – Results in softening of the stool and increased motility  – Onset: 24‐48 hours ...
IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS)
IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS)

... extract was also subjected to column chromatography to obtain four fractions, these fractions were preliminary tested for antiplasmodial potency and methanol fraction which gave the most potent effect was fully evaluated and was refractionated to obtain the phenolic compounds. Phytochemical test, Th ...
Neurotransmitters
Neurotransmitters

... as transduction. Figure 02b shows the various components in the synapse. The vesicle contains the neuro-transmitters in the axon. The receptor is located on the surface of the dendrite to pick up the neuro-transmitters. The transporter is for recycling un-used neutrotransmitters back into the axon; ...
pps
pps

... COOH ...
Structure-based design of enzyme inhibitors and receptor ligands
Structure-based design of enzyme inhibitors and receptor ligands

... including several of these structural elements in a much simpler molecule, was not only very active but also highly selective, compared to its action on the homologous serine protease, trypsin. Removal of the β-diketone partial structure led to a significant reduction in biological activity which wa ...
A case of heroin overdose reversed by sublingually administered
A case of heroin overdose reversed by sublingually administered

... allows the clinical effects of buprenorphine to last significantly longer than would be expected based solely upon its elimination half-life. A combination pill, buprenorphine/naloxone, is available in the United States under the trade name Suboxone®. Because naloxone is absorbed poorly sublingually ...
Cardiac glycosides
Cardiac glycosides

... – doesn’t correlate with biological activity – only estimating approx 60% therapeutic material ...
Subetta treatment increases adiponectin secretion by - Zen-Bio
Subetta treatment increases adiponectin secretion by - Zen-Bio

... in most rodent models of T2D, as well as T2D patients; the degree of glycosylated adiponectin and “high-molecular weight/total adiponectin ratio,” which correlates with insulin sensitivity, were significantly decreased in T2D patients compared to healthy controls; high adiponectin levels are associa ...
Anticholinergics for Overactive Bladder Therapy: Central Nervous
Anticholinergics for Overactive Bladder Therapy: Central Nervous

... serve to extrude any unwanted substrates back into the circulation that have managed to enter into the epithelial cell (Figure 1) [37]. The best characterized of these efflux pumps is P-glycoprotein, a member of the multidrug resistance protein family [38]. Finally, various enzymes are found in the ...
Procedural Sedation for EMS
Procedural Sedation for EMS

... GABA is major inhibitory neurotransmitter in CNS 3 types of receptors: GABA-A, GABA-B, GABA-C GABA-A overwhelmingly numerically dominant receptor in CNS BZO bind and allosterically modify receptor Potentiate GABA response Increase hyperpolarization Increase neuronal inhibition at all levels of the n ...
מבחן גמר בנוירולוגיה - 2008
מבחן גמר בנוירולוגיה - 2008

... from the disease which the drug is intended to treat c. Phase III trials are intended to verify the safety of the drug and its side effects and does not concern with efficacy of drug d. Data concerning the side effects of the drug is collected during phase IV after the initial marketing of the drug ...
Valium (diazepam)
Valium (diazepam)

... its approved indications is called its labeled use. In clinical practice, however, physicians often prescribe medications for unlabeled (“off-label”) uses when published clinical studies, case reports, or their own clinical experiences support the efficacy and safety of those treatments. Physicians ...
noradrenergic neuroeffector transmission as a target of drug action.
noradrenergic neuroeffector transmission as a target of drug action.

... hypertrophy- obstruction of urine flow through the bladder neck. ...
Pharmacological Approaches to Fat Loss: Targeting
Pharmacological Approaches to Fat Loss: Targeting

... to animals (4 mg/kg) as compared to humans (up to 40 µg/day). Slow release Salbutamol has been shown to increase voluntary muscle strength in healthy men.30,31 Research showing preservation of lean tissue and significantly improved protein deposition in response to treatment with ephedrine during ca ...
Lipid mediators of tumor necrosis factor-alpha-induced uveitis.
Lipid mediators of tumor necrosis factor-alpha-induced uveitis.

... many of the hemodynamic and biochemical changes that are induced by infusion of PAF or endotoxin in many species.21"2330 Based on the results shown in Table 3 and in the inflammatory index (Table 4), SRI 63-441 plus indomethacin most effectively reduced TNFa-induced uveitis. This finding highlighted ...
Uncoupling between noradrenergic and serotonergic neurons as a
Uncoupling between noradrenergic and serotonergic neurons as a

... of a1b-AR in KO mice since pre-treatment with prazosin abolished differences observed between WT and a1b-AR KO mice. Moreover, differences in locomotor responses were maintained when D-amphetamine, cocaine or morphine was administered repeatedly, only weak behavioral sensitization occurring in a1b-A ...
PGX Test Monographs
PGX Test Monographs

... CYP286 enzyme activity defines a normal or an abnormal (intermediate or poor) metabolizer status for a given individual. Several variant alleles have been identified and result in different CYP286 isoforms that functionally are fully active, partially active, inactive, or have increased activity. Th ...
Effects of a 5‐HT3 antagonist, ondansetron, on fasting and
Effects of a 5‐HT3 antagonist, ondansetron, on fasting and

... The subjects who were intubated had significantly lower fasting SBWC (P < 0.0002) compared with the group of subjects who were not intubated. Conclusions The 5-HT3 receptor antagonism increased fasting small bowel water. This was associated with reduced fasting antroduodenal Motility Index which may ...
Chapter 16 Cholinesterase Inhibitors
Chapter 16 Cholinesterase Inhibitors

... Several types of receptors involved in emetic response ...
CMC - Innovator Industry Presentation
CMC - Innovator Industry Presentation

... • The same principles should apply for quality characterization of biosimilar mAbs as for other biosimilars. • Available guidelines on Quality Characterization of mAbs (CHMP/BWP/157653/2007) and on Quality Issues of Biosimilar Products (CHMP/BWP/49348/2005) are applicable for biosimilar mAbs. There ...
Chapter 16 Cholinesterase Inhibitors
Chapter 16 Cholinesterase Inhibitors

... Several types of receptors involved in emetic response ...
< 1 ... 19 20 21 22 23 24 25 26 27 ... 107 >

NK1 receptor antagonist

Neurokinin 1 (NK1) antagonists are a novel class of medications that possesses unique antidepressant, anxiolytic, and antiemetic properties. The discovery of neurokinin 1 (NK1) receptor antagonists was a turning point in the prevention of nausea and vomiting associated with cancer chemotherapy.An example of a drug in this class is aprepitant. Chemotherapy-induced emesis appears to consist of acute and delayed phases. So far, the acute phase emesis responds to 5-HT3 antagonists while the delayed phase remains difficult to control. The discovery and development of NK1 receptor antagonists have elicited antiemetic effect in both acute and especially in delayed phases of emesis.The first registered clinical use of NK1 receptor antagonists was the treatment of emesis, associated with cancer chemotherapy.
  • studyres.com © 2026
  • DMCA
  • Privacy
  • Terms
  • Report